Merck wins FDA approval of sotatercept for rare lung disease [Seeking Alpha]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Seeking Alpha
Merck shares are up ~5% in after-hours trading. The approval is considered a major victory for patients as Winrevair tackles the source of PAH, rather than currently available therapies which just treat symptoms. The drug will cost $14,000 per vial without insurance, which is given to the vast majority of patients every three weeks, according to T he Wall Street Journal . That comes out to roughly $242,000 per year. Merck gained sotatercept in September 2021 through its $11.5B acquisition of Acceleron Pharma. United Therapeutics ( UTHR ), which markets Tyvaso and Remodulin (treprostinil) for PAH symptoms, is down 7% in after-hours trading. Recommended For You More Trending News Recommended For You More Trending News About MRK Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- New Jersey woman receives pig kidney and heart pump [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Grandmother Becomes Second Patient to Receive Kidney From Gene-Edited Pig [The New York Times]The New York Times
- Surgeons Perform World's First Combined Heart Pump And Pig Kidney Transplant—Latest Breakthrough Involving Pig Organ [Forbes]Forbes
- Doctors combine a pig kidney transplant and a heart device in bid to extend a woman’s life [MSNBC.com]MSNBC.com
- New Jersey woman recovering after receiving successful pig kidney transplant [FOX News]FOX News
UTHR
Earnings
- 2/21/24 - Beat
UTHR
Sec Filings
- 4/25/24 - Form 4
- 4/23/24 - Form 4
- 4/23/24 - Form 4
- UTHR's page on the SEC website